Search Results - "Vanuga, P"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    Effect of growth hormone on bone status in growth hormone-deficient adults by Kuzma, M, Homerova, Z, Dlesk, A, Koller, T, Killinger, Z, Vanuga, P, Lazurova, I, Tomkova, S, Payer, J

    Published in Bratislavské lékarské listy (2013)
    “…Growth hormone deficiency (GHD) is associated with reduced bone mineral content and increased risk of osteoporotic fractures. Reduced peak bone mass might…”
    Get full text
    Journal Article
  3. 3

    Pathophysiology of growth hormone secretion disorders and their impact on bone microstructure as measured by trabecular bone score by Kužma, M, Killinger, Z, Jackuliak, P, Vaňuga, P, Hans, D, Binkley, N, Payer, J

    Published in Physiological research (01-01-2019)
    “…This article is focused on endocrine-mediated osteoporosis caused by growth hormone (GH) disorders; adult GH deficiency and acromegaly. GH and insulin like…”
    Get full text
    Journal Article
  4. 4

    The Long-Term Effects of Growth Hormone Replacement on Bone Mineral Density and Trabecular Bone Score: Results of the 10-Year Prospective Follow-up by Vaňuga, P, Kužma, M, Stojkovičová, D, Smaha, J, Jackuliak, P, Killinger, Z, Payer, J

    Published in Physiological research (30-11-2021)
    “…There are only few studies concerning about long-term effect of growth hormone (GH) replacement therapy on bone mineral density and bone microstructure. To…”
    Get full text
    Journal Article
  5. 5

    Impact of the growth hormone replacement on bone status in growth hormone deficient adults by Kužma, M, Kužmová, Z, Zelinková, Z, Killinger, Z, Vaňuga, P, Lazurová, I, Tomková, S, Payer, J

    Published in Growth hormone & IGF research (01-02-2014)
    “…Abstract Introduction Growth hormone deficiency (GHD) is associated with reduced bone mineral density (BMD). GH replacement has positive effect on BMD but the…”
    Get full text
    Journal Article
  6. 6

    The low-dose (1 microg) cosyntropin test (LDT) for primary adrenocortical insufficiency: Defining the normal cortisol response and report on first patients with Addison disease confirmed with LDT by Pura, M, Kreze, Jr, A, Kentos, P, Vanuga, P

    “…The validity of low-dose 1 microg cosyntropin test (LDT) is reported mainly for the assessment of secondary adrenocortical insufficiency (AI). Likewise the…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH by Touraine, Philippe, D'Souza, Gwyn A, Kourides, Ione, Abs, Roger, Barclay, Paul, Xie, Rujia, Pico, Antonio, Torres-Vela, Elena, Ekman, Bertil

    Published in European journal of endocrinology (01-10-2009)
    “…ObjectiveChanges observed during adult GH deficiency (GHD) are most often reversed with the administration of recombinant human GH (rhGH). To avoid daily…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Primary B-cell pituitary lymphoma of the Burkitt type: case report of the rare clinic entity with typical clinical presentation by Kozáková, D, Macháleková, K, Brtko, P, Szépe, P, Vanuga, P, Pura, M

    Published in Časopis lékařů českých (2008)
    “…Primary CNS lymphomas (PCNSLs) constitute 3% of all intracranial neoplasms. From these, primary pituitary lymphomas (PPLs) represent extremely rare clinical…”
    Get more information
    Journal Article
  11. 11

    Genetic background of tumors originating from adrenomedullar and extraadrenal chromaffin tissue--update by Vanuga, P, Pura, M, Kreze, Jr, A

    Published in Vnitřní lékar̆stvĭ (01-12-2010)
    “…It is anticipated that an inherited/familial forms of pheochromocytomas cause approximately 20% of all pheochromocytomas. Therefore, the classic "rule of 10"…”
    Get more information
    Journal Article
  12. 12

    Genetic background of adrenal cortex tumours--news by Kreze, Jr, A, Vanuga, P, Pura, M

    Published in Vnitřní lékar̆stvĭ (01-12-2010)
    “…This review has summarized the current knowledge of the genetic background of tumors originating from adrenocortical tissue, manifested as a part of inherited…”
    Get more information
    Journal Article
  13. 13

    Autoimmune polyendocrine syndrome type 2 associated with autoimmune hypophysitis and coeliac disease by Hrubisková, K, Jackuliak, P, Vanuga, P, Pura, M, Payer, J

    Published in Vnitřní lékar̆stvĭ (01-11-2010)
    “…Autoimmune polyendocrine syndromes (APS) are organ-specific autoimmune disorders affecting multiple endocrine glands; these are gradually destroyed by action…”
    Get more information
    Journal Article
  14. 14

    Influence of Disease Activity and Body Composition Parameters on Cross-Sectional Area of the Median Nerve in Acromegalic Patients by Ságová, I., Pavai, D., Kantárová, D., Holováčová, D., Kužma, M., Payer, J., Vaňuga, P.

    Published in Physiological research (21-12-2021)
    “…Carpal tunnel syndrome (CTS) is neuropathy that occurs due to compression of the median nerve in the carpal tunnel. Acromegaly is one of the important causes…”
    Get full text
    Journal Article
  15. 15

    Influence of Disease Activity and Body Composition Parameters on Cross-Sectional Area of the Median Nerve in Acromegalic Patients by Ságová, I, Pavai, D, Kantárová, D, Holováčová, D, Kužma, M, Payer, J, Vaňuga, P

    Published in Physiological research (30-12-2021)
    “…Carpal tunnel syndrome (CTS) is neuropathy that occurs due to compression of the median nerve in the carpal tunnel. Acromegaly is one of the important causes…”
    Get full text
    Journal Article
  16. 16

    Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene) by Rosa, J, Vanuga, P, Payer, J, Svobodník, A

    Published in Vnitřní lékar̆stvĭ (01-03-2008)
    “…Osteoporosis is a disease causing higher bone fragility and bone ruptures occurring even in minimal traumas. Good patient compliance is the prerequisite for…”
    Get more information
    Journal Article
  17. 17

    Incidence of thyroid cancer in Slovakia: extensive evidence from one centre in the context of national data by Vanuga, P, Pura, M, Plesko, I, Ondrusová, M

    Published in Časopis lékařů českých (2007)
    “…In this paper the authors summarise the primary malignant thyroid tumors (p.m.t.t.) incidence data from their centre over the period 1984-2005. The results are…”
    Get more information
    Journal Article
  18. 18

    Occurrence of primary aldosteronism in a group of ambulatory hypertensive patients by Kreze, Jr, A, Okálová, D, Vanuga, P, Putz, Z, Kodaj, J, Hrnciar, J

    Published in Vnitřní lékar̆stvĭ (01-01-1999)
    “…Findings pertaining to the diagnosis and treatment of primary aldosteronism are rapidly expanding. In the present work the authors focused attention on the…”
    Get more information
    Journal Article
  19. 19

    The Long-Term Effects of Growth Hormone Replacement on Bone Mineral Density and Trabecular Bone Score: Results of the 10-Year Prospective Follow-up by Vaňuga, P, Kužma, M, Stojkovičová, D, Smaha, J, Jackuliak, P, Killinger, Z, Payer, J

    Published in Physiological research (30-11-2021)
    “…There are only few studies concerning about long-term effect of growth hormone (GH) replacement therapy on bone mineral density and bone microstructure. To…”
    Get more information
    Journal Article